MAPK14 and Alzheimer disease: Qiu et al. used network pharmacology and molecular docking techniques to explore the potential mechanisms ofAcorus calamusin AD treatment, identifying four active components associated with multiple AD-related targets (e.g., AKT1 and MAPK14) that regulated the oxidative stress and anti-inflammatory pathways.